DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE Amex: AXK) today announced that it signed a technology evaluation agreement for its BACcel™ rapid diagnostic system with a global diagnostics company. The short-term agreement includes an option for a license to complete product development, obtain regulatory approvals, and produce and market innovative diagnostic products based on the technology in global markets. The agreement calls for an initial payment plus scheduled payments of additional funds until completion of data evaluation.
